Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MRStain

Financiado

Cerrado

Non-invasive staining of tissue microstructure in temporal lobe epilepsy using i...

Non-invasive staining of tissue microstructure in temporal lobe epilepsy using in- vivo MRI Ex-vivo histology is the gold standard to investigate human brain microstructure. However, its invasive nature precludes its use in monitoring disease progression and the investigation of the pathophysiological origin of neurologi... ver más

30/06/2029

UNIVERSITÄTSKLINIK...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-05-19

ERC-2022-COG: ERC CONSOLIDATOR GRANTS Scope:Objectives

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

UNIVERSITÄTSKLINIKUM SCHLESW...

1.46M€ | Lider

UKE

533.69K€ | Participante

MPG

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

HMRI Non Invasive In Vivo Histology in Health and Disease Using M... 2M€ Cerrado

SAF2017-91824-EXP IMAGEN DE RESONANCIA MAGNETICA DE TRACTOS NEURALES ACTIVOS 18K€ Cerrado

CONNECT Consortium Of Neuroimagers for the Noninvasive Exploration o... 3M€ Cerrado

MRI-STRUCTURE MRI Signal To Recover Unique Cerebral TissUe Response to cha... 158K€ Cerrado

MICROBRADAM Advanced MR methods for characterization of microstructural... 540K€ Cerrado

SPECIFIC fMRI From surrogate hemodynamics based fMRI towards direct functi... 161K€ Cerrado

Duración del proyecto: 73 meses Fecha Inicio: 2023-05-19
Fecha Fin: 2029-06-30

Líder del proyecto

UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Ex-vivo histology is the gold standard to investigate human brain microstructure. However, its invasive nature precludes its use in monitoring disease progression and the investigation of the pathophysiological origin of neurological disorders. MRStain will address this shortcoming by exploiting the sensitivity of the Magnetic Resonance Imaging (MRI) signal to estimate aggregated histological metrics in the human brain non-invasively. Like established histology staining methods (e.g., myelin-basic protein), MRStain will be sensitive to changes in cellular populations, axons, myelin, and iron. This will be achieved by augmenting the MRI measurements with computational biophysical models, which can disentangle tissue metrics at the micron-scale using the macroscopic spatial resolution (1–4 mm) of MRI. However, the clinical use of these models has not been employed because their validity and generalizability across disease trajectories has yet to be tested against the ex-vivo histological gold standard. This project will address this shortcoming by generating a globally unique multi-modal dataset that combines novel in-vivo and ex-vivo MRI techniques with biophysical models as well as cutting-edge large-scale 3D histology. The project will benefit from a unique translational university hospital environment where large sections of freshly excised brain tissue from drug-resistant temporal lobe epilepsy patients (TLE, 80 sections of about 3 x 2 x cm^3) can be examined, enabling in-vivo MRI-based biophysical tissue parameters to be validated against their histological gold standard. I will develop an MRStain model to identify TLE relevant changes that will achieve a paradigm shift in how epilepsy is treated by identifying target brain areas for surgery that will help to predict seizure-free outcome after surgery. The final validated MRStain models will also pave the way for similar noninvasive investigations of other neuropsychiatric diseases with unprecedented precision.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores